Long-term Eculizumab Therapy in a Child With Refractory Immune Complex–Mediated Membranoproliferative Glomerulonephritis

Bibliographic Details
Main Authors: Rahul Chanchlani, Paul Thorner, Seetha Radhakrishnan, Diane Hebert, Valerie Langlois, Steven Arora, David Barth, Daniel Cattran, Michael Kirschfink, Christoph Licht
Format: Article
Language:English
Published: Elsevier 2018-03-01
Series:Kidney International Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024917303819
_version_ 1819077384093040640
author Rahul Chanchlani
Paul Thorner
Seetha Radhakrishnan
Diane Hebert
Valerie Langlois
Steven Arora
David Barth
Daniel Cattran
Michael Kirschfink
Christoph Licht
author_facet Rahul Chanchlani
Paul Thorner
Seetha Radhakrishnan
Diane Hebert
Valerie Langlois
Steven Arora
David Barth
Daniel Cattran
Michael Kirschfink
Christoph Licht
author_sort Rahul Chanchlani
collection DOAJ
first_indexed 2024-12-21T18:56:20Z
format Article
id doaj.art-c71f98acd979453580109f3999ee8ca2
institution Directory Open Access Journal
issn 2468-0249
language English
last_indexed 2024-12-21T18:56:20Z
publishDate 2018-03-01
publisher Elsevier
record_format Article
series Kidney International Reports
spelling doaj.art-c71f98acd979453580109f3999ee8ca22022-12-21T18:53:36ZengElsevierKidney International Reports2468-02492018-03-013248248510.1016/j.ekir.2017.08.019Long-term Eculizumab Therapy in a Child With Refractory Immune Complex–Mediated Membranoproliferative GlomerulonephritisRahul Chanchlani0Paul Thorner1Seetha Radhakrishnan2Diane Hebert3Valerie Langlois4Steven Arora5David Barth6Daniel Cattran7Michael Kirschfink8Christoph Licht9Division of Nephrology, The Hospital for Sick Children, Toronto, Ontario, CanadaPaediatric Laboratory Medicine, University of Toronto, Toronto, Ontario, CanadaDivision of Nephrology, The Hospital for Sick Children, Toronto, Ontario, CanadaDivision of Nephrology, The Hospital for Sick Children, Toronto, Ontario, CanadaDivision of Nephrology, The Hospital for Sick Children, Toronto, Ontario, CanadaDivision of Nephrology, McMaster Children’s Hospital, Hamilton, Ontario, CanadaDepartment of Internal Medicine, University of Toronto, Toronto, Ontario, CanadaDepartment of Internal Medicine, University of Toronto, Toronto, Ontario, CanadaInstitute for Immunology, University of Heidelberg, Heidelberg, GermanyDivision of Nephrology, The Hospital for Sick Children, Toronto, Ontario, Canadahttp://www.sciencedirect.com/science/article/pii/S2468024917303819
spellingShingle Rahul Chanchlani
Paul Thorner
Seetha Radhakrishnan
Diane Hebert
Valerie Langlois
Steven Arora
David Barth
Daniel Cattran
Michael Kirschfink
Christoph Licht
Long-term Eculizumab Therapy in a Child With Refractory Immune Complex–Mediated Membranoproliferative Glomerulonephritis
Kidney International Reports
title Long-term Eculizumab Therapy in a Child With Refractory Immune Complex–Mediated Membranoproliferative Glomerulonephritis
title_full Long-term Eculizumab Therapy in a Child With Refractory Immune Complex–Mediated Membranoproliferative Glomerulonephritis
title_fullStr Long-term Eculizumab Therapy in a Child With Refractory Immune Complex–Mediated Membranoproliferative Glomerulonephritis
title_full_unstemmed Long-term Eculizumab Therapy in a Child With Refractory Immune Complex–Mediated Membranoproliferative Glomerulonephritis
title_short Long-term Eculizumab Therapy in a Child With Refractory Immune Complex–Mediated Membranoproliferative Glomerulonephritis
title_sort long term eculizumab therapy in a child with refractory immune complex mediated membranoproliferative glomerulonephritis
url http://www.sciencedirect.com/science/article/pii/S2468024917303819
work_keys_str_mv AT rahulchanchlani longtermeculizumabtherapyinachildwithrefractoryimmunecomplexmediatedmembranoproliferativeglomerulonephritis
AT paulthorner longtermeculizumabtherapyinachildwithrefractoryimmunecomplexmediatedmembranoproliferativeglomerulonephritis
AT seetharadhakrishnan longtermeculizumabtherapyinachildwithrefractoryimmunecomplexmediatedmembranoproliferativeglomerulonephritis
AT dianehebert longtermeculizumabtherapyinachildwithrefractoryimmunecomplexmediatedmembranoproliferativeglomerulonephritis
AT valerielanglois longtermeculizumabtherapyinachildwithrefractoryimmunecomplexmediatedmembranoproliferativeglomerulonephritis
AT stevenarora longtermeculizumabtherapyinachildwithrefractoryimmunecomplexmediatedmembranoproliferativeglomerulonephritis
AT davidbarth longtermeculizumabtherapyinachildwithrefractoryimmunecomplexmediatedmembranoproliferativeglomerulonephritis
AT danielcattran longtermeculizumabtherapyinachildwithrefractoryimmunecomplexmediatedmembranoproliferativeglomerulonephritis
AT michaelkirschfink longtermeculizumabtherapyinachildwithrefractoryimmunecomplexmediatedmembranoproliferativeglomerulonephritis
AT christophlicht longtermeculizumabtherapyinachildwithrefractoryimmunecomplexmediatedmembranoproliferativeglomerulonephritis